Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
about
Enhanced transduction and replication of RGD-fiber modified adenovirus in primary T cellsNew insights into IL-12-mediated tumor suppression.Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.Cellular immunotherapy using dendritic cells against multiple myelomaEnhancement of dendritic cells as vaccines for cancerAdenovirus as vehicle for anticancer genetic immunotherapy.Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections.Immunotherapy of cancer by IL-12-based cytokine combinationsDendritic cell vaccination.Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.Engineering dendritic cells to enhance cancer immunotherapy.Developments in Viral Vector-Based Vaccines.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?Enhanced activation of human dendritic cells by silencing SOCS1 and activating TLRs simultaneously.
P2860
Q33862517-7C530EB8-BB57-4C68-BEC7-AD7B32B19E7FQ34436897-5D3CDA5A-A943-4ABD-BC80-443F12A81A80Q34443707-5AFA4734-6DB8-4CDF-97DA-4BF69070747DQ35144428-A6AE3D8E-A80D-4F2E-92CF-2F0E838A7983Q35865581-B7606B04-F837-4C1E-98D8-B6A2238D48D2Q36209210-288A87B7-AFFC-4FB1-85C5-1941690B2CA2Q36288930-FCB9B1C6-58B7-4CC6-ADD9-99DA1AAD324CQ36349567-F089F7DE-F00F-4AB1-8336-FB2E28347B5DQ36724827-4ED058DE-1B91-433D-95BE-873341734CAAQ36899104-EDA30C40-9BD9-4AF6-851C-88B5F42E1CB7Q37513871-209A1C18-D181-4E8F-9245-B4A12601207AQ37735454-02001304-F5A2-4047-8821-129BE278B8B3Q37862064-41C6B76A-2C44-4AD0-873B-4F1978444E5CQ38582090-22FD7DAD-ABE5-4331-B2F4-52242212FE39Q38703318-DDCD5621-5528-406F-9DDD-ABB4C6ED7118Q38844559-12146A65-B631-47A0-8146-071E3CFAD2C2Q41520681-8F8445CE-3DFE-4BCB-82F3-03AD9EC3AF82Q43510234-41D6AB94-0224-4461-B70F-EE039FC33249
P2860
Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Immunological properties and v ...... ed antigen and interleukin-12.
@en
Immunological properties and v ...... ed antigen and interleukin-12.
@nl
type
label
Immunological properties and v ...... ed antigen and interleukin-12.
@en
Immunological properties and v ...... ed antigen and interleukin-12.
@nl
prefLabel
Immunological properties and v ...... ed antigen and interleukin-12.
@en
Immunological properties and v ...... ed antigen and interleukin-12.
@nl
P2093
P2860
P356
P1433
P1476
Immunological properties and v ...... ed antigen and interleukin-12.
@en
P2093
Akira Yamamoto
Naoki Okada
Sayaka Iiyama
Shinsaku Nakagawa
Tadanori Mayumi
Takao Hayakawa
Takuya Fujita
Yuka Okada
P2860
P2888
P356
10.1038/SJ.CGT.7700772
P577
2005-01-01T00:00:00Z
P5875
P6179
1022353332